These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9244653)
1. [Molecular etiology of colorectal carcinogenesis, clinical manifestations and therapy]. Jacobasch G; Jacobasch KH Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):125-33. PubMed ID: 9244653 [TBL] [Abstract][Full Text] [Related]
2. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents]. Couturier D Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848 [TBL] [Abstract][Full Text] [Related]
3. Multistep carcinogenesis in colorectal cancers. Takami K; Yana I; Kurahashi H; Nishisho I Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Shin KH; Park YJ; Park JG Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536 [TBL] [Abstract][Full Text] [Related]
5. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair. Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435 [TBL] [Abstract][Full Text] [Related]
6. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. Breuhahn K; Singh S; Schirmacher P; Bläker H J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352 [TBL] [Abstract][Full Text] [Related]
7. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families. Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729 [TBL] [Abstract][Full Text] [Related]
9. Genetic predispositions to colorectal cancer. Thomas G; Olschwang S Pathol Biol (Paris); 1995 Mar; 43(3):159-64. PubMed ID: 7675542 [TBL] [Abstract][Full Text] [Related]
10. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue. Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK; Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962 [TBL] [Abstract][Full Text] [Related]
12. [Molecular genetics of colorectal cancer and carcinogenesis]. Panduro Cerda A; Lima González G; Villalobos JJ Rev Invest Clin; 1993; 45(5):493-504. PubMed ID: 8134731 [TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to colorectal cancer. de la Chapelle A Nat Rev Cancer; 2004 Oct; 4(10):769-80. PubMed ID: 15510158 [TBL] [Abstract][Full Text] [Related]
14. Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Diergaarde B; Braam H; Vasen HF; Nagengast FM; van Muijen GN; Kok FJ; Kampman E Clin Gastroenterol Hepatol; 2007 Jun; 5(6):736-42. PubMed ID: 17544999 [TBL] [Abstract][Full Text] [Related]
15. [Mutational studies of adenomatous polyposis coli gene in carcinomas from patients with hereditary non-polyposis colorectal cancers]. Huang J; Jin SH; Zhang SZ; Zheng S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):196-9. PubMed ID: 12778442 [TBL] [Abstract][Full Text] [Related]
16. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Miyaki M; Iijima T; Kimura J; Yasuno M; Mori T; Hayashi Y; Koike M; Shitara N; Iwama T; Kuroki T Cancer Res; 1999 Sep; 59(18):4506-9. PubMed ID: 10493496 [TBL] [Abstract][Full Text] [Related]
17. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients. Müller O; Nimmrich I; Finke U; Friedl W; Hoffmann I Genes Chromosomes Cancer; 1998 May; 22(1):37-41. PubMed ID: 9591632 [TBL] [Abstract][Full Text] [Related]
18. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer. Edelmann L; Edelmann W Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):91-9. PubMed ID: 15264277 [TBL] [Abstract][Full Text] [Related]
19. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome. Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192 [TBL] [Abstract][Full Text] [Related]
20. Mouse models for colorectal cancer. Heyer J; Yang K; Lipkin M; Edelmann W; Kucherlapati R Oncogene; 1999 Sep; 18(38):5325-33. PubMed ID: 10498885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]